A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The Journal of Nuclear Medicine. ...
20 minutes ago
0
0
Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.
4 hours ago
0
0
The U.S. population is getting older fast and many Americans are unsure what aging will look like for them, a new national survey shows.
4 hours ago
0
0
Record numbers of men and women globally are now estimated to have reduced kidney function, a new study shows. Figures rose from 378 million people with the disease in 1990 to 788 million in 2023 as the world population grew ...
5 hours ago
0
46
Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term.
5 hours ago
0
0
The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly reduce the risk of kidney disease progression, hospitalization, and death in people with and without ...
6 hours ago
0
0
You may think your home is safe once the outlet covers are in, the baby gates are locked and the sharp corners are padded, but some of the biggest dangers to babies and toddlers aren't the ones parents can see.
6 hours ago
0
0
New research reveals that contrary to conventional belief, primary glomerular diseases are not necessarily benign for children and young adults. In fact, some subsets of children and young adults may experience faster kidney ...
6 hours ago
0
0
Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and kidney- protective effects.
6 hours ago
0
0
An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney disease (CKD) would have benefits that outweigh the harm from a systolic blood pressure target of ...
6 hours ago
0
0
